Payer PolicyActive
Aerosolized or Irrigated Anti-infectives for Sinusitis
AETNA-CPB-0593
Aetna
Effective: September 7, 2023
Updated: December 6, 2025
created · Dec 2, 2025
Policy Summary
Aetna considers nasally aerosolized or irrigated anti-infectives (topical antibiotics and antifungals) experimental and investigational and therefore not covered for the treatment of acute or chronic sinusitis because randomized trials and professional guidelines show inadequate or no clinical benefit. There are no clinical criteria under which these therapies are deemed medically necessary, and topical/systemic antifungals showed no benefit with higher adverse events.
Coverage Criteria Preview
Key requirements from the full policy
"None. (The policy does not list any covered indications."
Sign up to see full coverage criteria, indications, and limitations.